Literature DB >> 11879988

The role of ketamine on plasma cocaine pharmacokinetics in rat.

Hany Z Rofael1, Mohamed S Abdel-Rahman.   

Abstract

Ketamine has gained attention recently because of re-emergence of its abuse especially in combination with cocaine. When more than one drug is present simultaneously, the potential for drug--drug interaction exists, which can be pharmacokinetic, pharmacodynamic or both in nature. The objective of this study was to investigate the effect of ketamine on plasma cocaine pharmacokinetics to assess the role that the kinetic component may play in the interaction of these agents. Moreover, the effect of repetitive administration of ketamine pretreatment on the pharmacokinetics of cocaine was addressed. Male Sprague-Dawley rats were treated with cocaine alone (5 mg/kg i.v.), ketamine alone (100 mg/kg by gavage), or ketamine followed by cocaine (the same routes and doses). Blood samples were withdrawn at different time points post-injection and analyzed for determination of cocaine, its metabolites (benzoylecgonine and norcocaine) and ketamine. The results demonstrated that ketamine caused a significant decrease in cocaine's area under the curve (AUC) and elimination half-life while its total clearance was increased. The AUC of benzoylecgonine was increased by 1.5-fold after the combination compared with cocaine alone. However, cocaine did not affect ketamine's pharmacokinetic parameters. In the pretreatment study, ketamine was given orally for 3 days, followed 18 h later by a single i.v. of cocaine. Further enhancement of cocaine metabolism occurred with the appearance of norcocaine. This investigation revealed that ketamine enhances cocaine metabolism and may affect its toxicological profile.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11879988     DOI: 10.1016/s0378-4274(02)00008-5

Source DB:  PubMed          Journal:  Toxicol Lett        ISSN: 0378-4274            Impact factor:   4.372


  7 in total

1.  Pharmacokinetic comparison between the long-term anesthetized, short-term anesthetized and conscious rat models in nasal drug delivery.

Authors:  Yin Cheong Wong; Shuai Qian; Zhong Zuo
Journal:  Pharm Res       Date:  2014-02-20       Impact factor: 4.200

2.  Intra-accumbal Tat1-72 alters acute and sensitized responses to cocaine.

Authors:  S B Harrod; C F Mactutus; S Fitting; U Hasselrot; R M Booze
Journal:  Pharmacol Biochem Behav       Date:  2008-10       Impact factor: 3.533

3.  Behavioral alterations of zebrafish larvae after early embryonic exposure to ketamine.

Authors:  Luís M Félix; Luís M Antunes; Ana M Coimbra; Ana M Valentim
Journal:  Psychopharmacology (Berl)       Date:  2016-12-08       Impact factor: 4.530

4.  GLYX-13, a NMDA receptor glycine-site functional partial agonist, induces antidepressant-like effects without ketamine-like side effects.

Authors:  Jeffrey Burgdorf; Xiao-lei Zhang; Katherine L Nicholson; Robert L Balster; J David Leander; Patric K Stanton; Amanda L Gross; Roger A Kroes; Joseph R Moskal
Journal:  Neuropsychopharmacology       Date:  2012-12-05       Impact factor: 7.853

5.  Pharmacokinetic Effects of l-Tetrahydropalmatine on Ketamine in Rat Plasma by Ultraperformance Liquid Chromatography Tandem Mass Spectrometry.

Authors:  Yan Du; Hongliang Su; Jie Cao; Zhiwen Wei; Yujin Wang; Keming Yun
Journal:  Biomed Res Int       Date:  2020-07-06       Impact factor: 3.411

Review 6.  Metabolism and metabolomics of ketamine: a toxicological approach.

Authors:  Ricardo Jorge Dinis-Oliveira
Journal:  Forensic Sci Res       Date:  2017-02-20

7.  Metaplastic Effects of Ketamine and MK-801 on Glutamate Receptors Expression in Rat Medial Prefrontal Cortex and Hippocampus.

Authors:  Alessandro Piva; Lucia Caffino; Francesca Mottarlini; Nicholas Pintori; Fernando Castillo Díaz; Fabio Fumagalli; Cristiano Chiamulera
Journal:  Mol Neurobiol       Date:  2021-03-15       Impact factor: 5.590

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.